Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kezar Life Sciences

Kezar Life Sciences
2015 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
KZR STOCK SYMBOL
$17.00 SHARE PRICE (As of Thursday Closing)
Description

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and protein secretion program.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 4000 Shoreline Court
  • Suite 300
  • South San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kezar Life Sciences’s full profile, request a free trial.

Kezar Life Sciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$14.77 - $36.33 $325M $18.27 -$3.89 97K 19.1M

Kezar Life Sciences Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 231,729 477,852
Revenue 0 0 0 0
EBITDA (27,043) (24,036) (8,574) (8,836)
Net Income (25,862) (23,167) (8,517) (8,990)
Total Assets 113,056 114,682 54,222 11,424
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kezar Life Sciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Kezar Life Sciences‘s full profile, request access.

Request full access to PitchBook

Kezar Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Kezar Life Sciences‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Kezar Life Sciences Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MacroGenics Formerly VC-backed Rockville, MD 000 00000 00000000000 00000
000000 00000000000 Formerly VC-backed San Jose, CA 00 000.00 00000000 000.00
0000 0000000000 Venture Capital-Backed Beijing, China 000.00 00000000000 000.00
000000 00000000000 Venture Capital-Backed Cambridge, MA 0 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Kezar Life Sciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Kezar Life Sciences‘s full profile, request access.

Request full access to PitchBook

Kezar Life Sciences Executive Team (6)

Name Title Board
Seat
Contact
Info
John Fowler Co-Founder, Chief Executive Officer & Board Member
Marc Belsky Chief Financial Officer
Christopher Kirk Ph.D Co-Founder, Chief Scientific Officer, President and Board Member
Michael Wolfe Director of Finance & Operations
Jack Taunton Ph.D Co-Founder
You’re viewing 5 of 6 executives. Get the full list »

Kezar Life Sciences Board Members (8)

Name Representing Role Since Contact
Info
Bihua Chen Cormorant Asset Management Board Member 000 0000
Franklin Berger Self Board Member 000 0000
Gerald Chan Ph.D Morningside Group Board Member 000 0000
Graham Cooper Self Board Member 000 0000
Jason Dinges Ph.D Morningside Group Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »